Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-01-19
1998-02-03
Jarvis, William R. A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, A61K 3810, A61K 3804
Patent
active
057144680
ABSTRACT:
The invention is a method for reducing headache pain and symptoms associated with the onset or occurrence of headache in mammals. The method is performed by delivering an invertebrate presynaptic neurotoxin to a mammal extramuscularly (preferably at a localized, site of pain), or at a site in one or more muscles (preferably muscles of the face, cranium and neck). The presynaptic neurotoxins administered according to the invention are those neurotoxins that are known to produce a reversible, flaccid paralysis of muscle tissue in mammals. The preferred neurotoxin for use in the method of the invention is Botulinum toxin, particularly Botulinum toxin A.
REFERENCES:
Physicians' Desk Reference, pp. 792-797, 1994.
Olosen, Clinical and pathophysiological observations in migraine and tension-type headach explained by integration of vacsular, supraspinal and myofascial inputs, Elsevier Science Publishers B.V. vol. 46, pp. 125-129, 1991.
Blitzer, et al., Abstract Title, The management of Hyperfunctional lines with Botulinum Toxin: A Collaborative study of 200 patients, 1993.
Borodic, et al., Botulinum A toxin for treatment of Aberrant facial nerve regenration, P & R Surgery, May 1993, vol. 91, No.6 pp. 1042-1045.
Borodic, et al., Botulinum A Toxin for the treatment of Adult-Onset Spasmodic Torticollis, P & R Surgery Feb. 1991, vol. 87, No. 2, pp. 285-289.
Jankovic, et al., Therapeutic uses of Botulinum Toxin, New England Journal of Medicine, Apr. 25, 1991, 324:1186-1194.
Keen, et al., Botulinum Toxin for Hyperkinetic Facial Lines: Results of a Double Placebo Controlled Study, Jan. 15, 1993, Presented in Part at the Winter Meeting of the American Academy of Facial Plastic and Reconstructive Surgery, Boca Raton, Florida.
Anderson et al, Medline Abstracts, abstract No. 93059130, 1992.
Jedynak et al, Biological Abstracts, vol. 90, No. 7, abstract No. 79336, 1990.
Yakovleff et al., Biological Abstracts, vol. 97, No. 3, abstract No. 33434, 1993.
LandOfFree
Method for reduction of migraine headache pain does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for reduction of migraine headache pain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for reduction of migraine headache pain will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-662412